Nevoid basal cell carcinoma syndrome (Gorlin Syndrome): Updated review of minimally invasive treatments

Cutis

Volumn 81, Issue 1, 2008, Pages 53-60

  Mitropoulos, Panagiotis ^a,c   Norman, Robert ^b  

^a Camp Long Troop Medical Clinic   (South Korea)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

^c APACHE POINT OBSERVATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOQUINOLINE DERIVATIVE; ANTINEOPLASTIC AGENT; FLUOROURACIL; IMIQUIMOD; IMMUNOLOGIC FACTOR; INTERFERON; RETINOID;

BASAL CELL CARCINOMA; BASAL CELL NEVUS SYNDROME; CRYOSURGERY; ELECTROCHEMOTHERAPY; HUMAN; PHOTOCHEMOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SKIN TUMOR;

AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; BASAL CELL NEVUS SYNDROME; CARCINOMA, BASAL CELL; CRYOSURGERY; ELECTROCHEMOTHERAPY; FLUOROURACIL; HUMANS; IMMUNOLOGIC FACTORS; INTERFERONS; PHOTOCHEMOTHERAPY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETINOIDS; SKIN NEOPLASMS;

EID: 39049085793     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (51)

1. Bitar GJ, Herman CK, Dahman MI, et al. Basal cell nevus syndrome: guidelines for early detection. Am Fam Physician. 2002;65:2501-2504.
2. Jaramillo-Ayerbe F. Cryosurgery in difficult to treat basal cell carcinoma. Int J Dermatol. 2000,39:223-229.
3. Mallon E, Dawber R. Cryosurgery in the treatment of basal cell carcinoma, assessment of one and two freeze-thaw cycle schedules. Dermatol Surg. 1996;22: 854-858.
4. Nordin P, Stenquist B. Five-year results of curettage-cryosurgery for 100 consecutive auricular non-melanoma skin cancers. J Laryngol Otol. 2002;116:893-898.
5. Elton RF. The appropriate use of liquid nitrogen. Prim Care. 1983;10:459-478.
6. Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. Br J Dermatol. 1999;141:415-423.
7. Buschmann W. A reappraisal of Cryosurgery for eyelid basal cell carcinomas. Br J Ophthalmol. 2002;86: 453-457.
8. 2 vaporization in the management of a patient with nevoid basal cell carcinoma syndrome. J Dermatol. 1998;25:10-12.
9. Spiller WF, Spiller RF. Treatment of basal cell carcinomas by a combination of curettage and cryosurgery. J Dermatol Surg Oncol. 1997;3:443-447.
10. Peck GL, DiGiovanna JJ, Sarnoff DS, et al. Treatment and prevention of basal cell carcinoma with oral isotretinoin. J Am Acad Dermatol. 1988;19:176-185.
11. Cristofolini M, Zumiani G, Scappini P, et al. Aromatic retinoid in the chemoprevention of the progression of nevoid basal-cell carcinoma syndrome. J Dermatol Surg Oncol. 1984;10:778-781.
12. Sanchez-Conejo-Mir J, Camacho F. Nevoid basal cell carcinoma syndrome: combined etretinate and surgical treatment. J Dermatol Surg Oncol. 1989;15:868-871.
13. Hodak E, Ginzburg A, David M, et al. Etretinate treatment of the nevoid basal cell carcinoma syndrome: therapeutic and chemopreventive effect. Int J Dermatol. 1987;26:606-609.
14. Sankowski A, Janik P, Jeziorska M, et al. The results of topical application of 13-cis-retinoic acid on basal cell carcinoma, a correlation of the clinical effect with histopathological examination and serum retinol level. Neoplasma. 1987;34:485-489.
15. Sankowski A, Janik P, Bogacka-Zatorska E. Treatment of basal cell carcinoma with 13-cis-retinoic acid. Neoplasma. 1984;31:615-618.
16. So PL, Lee K, Hebert J, et al. Topical tazarotene chemoprevention reduces basal cell carcinoma number and size in ptch1 +/- mice exposed to ultraviolet or ionizing radiation. Cancer Res. 2004;64:4385-4389.
17. Micali G, De Pasquale R, Caltabiano R, et al. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report. J Dermatolog Treat. 2002;13:123-127.
18. Geisse J, Caro I, Lindholm J, et al. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol. 2004;50:722-733.
19. Kagy M, Amonette R. The use of imiquimod 5% cream for the treatment of superficial basal cell carcinoma in a basal cell nevus syndrome patient. Dermatol Surg. 2000;26: 577-579.
20. Micali G, Lacarrubba F, Nasca MR, et al. The use of imiquimod 5% cream for the treatment of basal cell carcinomas as observed in Gorlin's syndrome. Clin Exp Dermatol. 2003;28(suppl 1):19-23.
21. Stockfletch E, Urlich C, Hauschild A, et al. Successful treatment of basal cell carcinomas in a nevoid basal cell carcinoma syndrome with topical 5% imiquimod. Eur J Dermatol. 2002;12:569-572.
22. Sullivan TP, Dearaujo T, Vincek V, et al. Evaluation of superficial basal cell carcinomas after treatment with imiquimod 5% cream or vehicle for apoptosis and lymphocyte phenotyping. Dermatol Surg. 2003;29:1167-1169.
23. Vidal D, Matias-Guiu X, Alomar A. Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma. J Clin Exp Dermatol. 2003;29: 518-525.
24. Strange PR, Lang PG Jr. Long-term management of basal cell nevus syndrome with topical tretinoin and 5-fluorouracil. J Am Acad Dermatol. 1992;27: 842-845.
25. Hazen PG, Taub SJ. Basal cell nevus syndrome, unresponsiveness of early cutaneous lesions to topical 5-fluorouracil or dinitrochlorobenzene. Dermatologica. 1984;168:287-289.
26. Tsuji T, Otake N, Nishimura M. Cryosurgery and topical fluorouracil: a treatment method for widespread basal cell epithelioma in basal cell nevus syndrome. J Dermatol. 1993;20:507-513.
27. Orenberg EK, Miller BH, Greenway HT, et al. The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma. J Am Acad Dermatol. 1992;27:723-728.
28. Miller BH, Shavin JS, Cognetta A, et al. Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel. J Am Acad Dermatol. 1997;36:72-77.
29. Wickramasinghe L, Hindson TC, Wacks H. Treatment of neoplastic skin lesions with intralesional interferon. J Am Acad Dermatol. 1989;20:71-74.
30. Greenway HT, Cornell RC, Tanner DJ, et al. Treatment of basal cell carcinoma with intralesional interferon. J Am Acad Dermatol. 1986;15:437-443.
31. Cornell RC, Green way HT, Tucker SB, et al. Intralesional Interferon therapy for basal cell carcinoma. J Am Acad Dermatol. 1990;23(4, pt 1):694-700.
32. Stenquist B, Wennberg AM, Gisslen H, et al. Treatment of aggressive basal cell carcinoma with intralesional interferon: evaluation of efficacy by Mohs surgery. J Am Acad Dermatol. 1992;27:65-69.
33. Sollitto RB, DiGiovanna JJ. Failure of interferon alfa and isotretinoin combination therapy in nevoid basal cell carcinoma syndrome. Arch Dermatol. 1996;132: 94-95.
34. Edwards L, Whiting D, Rogers D, et al. The effect of intralesional interferon gamma on basal cell carcinomas. J Am Acad Dermatol. 1990;22:496-500.
35. Farndon PA, Costello M. Naevoid basal cell carcinoma (Gorlin syndrome). Gorlin Syndrome Group Web site, http://www.gorlingroup.co.uk/treatments.htm. Accessed September 21, 2004.
36. Itkin A, Gilchrest BA. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome. Dermatol Surg. 2004;30: 1054-1061.
37. Tse DT, Kersten RC, Anderson RL. Hematoporphyrin photoradiation therapy in managing nevoid basal-cell carcinoma syndrome, a preliminary report. Arch Opthalmol. 1984;102:990-994.
38. Rifkin R, Reed B, Hetzel F, et al. Photodynamic therapy using SnET2 for basal cell nevus syndrome: case report. Clin Ther. 1997;19:639-641.
39. Wang I, Bendsoe N, Klinteberg CA, et al. Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial. Br J Dermatol. 2001;144:832-840.
40. Glass FL, Fenske NA, Jaroszeski M, et al. Bleomycin-mediated electrochemotherapy of basal cell carcinoma. J Am Acad Dermatol. 1996;34:82-86.
41. Glass LF, Jaroszeski M, Gilbert R, et al. Intralesional bleomycin-mediated electrochemotherapy in 20 patients with basal cell carcinoma. J Am Acad Dermatol. 1997;37: 596-599.
42. Heller R, Jaroszeski MJ, Reinigen DS, et al. Treatment of cutaneous and subcutaneous tumors with electrochemotherapy using intralesional bleomycin. Cancer. 1998;83:148-157.
43. Mir LM, Glass LF, Sersa G, et al. Effective treatment of cutaneous and subcutaneous malignant tumours by electrochemotherapy. Br J Cancer. 1998;77: 2336-2342.
44. Sersa G, Stabuc B, Cemazar M, et al. Electrochemotherapy with cisplatin: potentiation of local cisplatin antitumor effectiveness by application of electric pulses in cancer patients. Eur J Cancer. 1998;34:1213-1218.
45. Hall VL, Leppard BJ, McGill J. Treatment of basal cell carcinoma: comparison of radiotherapy and cryotherapy. Clin Radiol. 1986;37:33-34.
46. Thissen MR, Nieman FH, Ideler AH, et al. Cosmetic results of cryosurgery versus surgical excision for primary uncomplicated basal cell carcinomas of the head and neck. Dermatol Surg. 2000;26:759-764.
47. Beutner KR, Geisse JK, Helman D, et al. Therapeutic response of basal cell carcinoma to the immune response modifier imiquimod 5% cream. J Am Acad Dermatol. 1999;41:1002-1007.
48. Shumack S, Robinson J, Kossard S, et al. Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens. Arch Dermatol. 2002;138:1165-1171.
49. Marks R, Gebauer K, Shumack S, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol. 2001;44:807-813.
50. Romagosa R, Saap L, Givens M, et al. A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier. Dermatol Surg. 2000;26:338-340.
51. Soler AM, Angell-Petersen E, Warloe T, et al. Photodynamic therapy of superficial basal cell carcinoma with 5-aminolevulinic acid with dimethylsulfoxide and ethylendiaminetetraacetic acid: a comparison of two light sources. Photochem Photobiol. 2000;71:724-729.